ATE406448T1 - Diacylglycerin o-acyltransferase - Google Patents

Diacylglycerin o-acyltransferase

Info

Publication number
ATE406448T1
ATE406448T1 AT99930624T AT99930624T ATE406448T1 AT E406448 T1 ATE406448 T1 AT E406448T1 AT 99930624 T AT99930624 T AT 99930624T AT 99930624 T AT99930624 T AT 99930624T AT E406448 T1 ATE406448 T1 AT E406448T1
Authority
AT
Austria
Prior art keywords
nucleic acid
well
acid compositions
applications
diacylglycerin
Prior art date
Application number
AT99930624T
Other languages
English (en)
Inventor
Robert V Farese Jr
Sylvaine Cases
Steven Smith
Sandra K Erickson
Hubert Chen
Original Assignee
David Gladstone Inst
Us Gov Represented By The Dept
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/103,754 external-priority patent/US6344548B1/en
Application filed by David Gladstone Inst, Us Gov Represented By The Dept, Univ California filed Critical David Gladstone Inst
Application granted granted Critical
Publication of ATE406448T1 publication Critical patent/ATE406448T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436Fatty acid esters
    • C12P7/6445Glycerides
    • C12P7/6463Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99930624T 1998-06-24 1999-06-23 Diacylglycerin o-acyltransferase ATE406448T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/103,754 US6344548B1 (en) 1998-06-24 1998-06-24 Diacylglycerol o-acyltransferase
US10777198P 1998-11-09 1998-11-09

Publications (1)

Publication Number Publication Date
ATE406448T1 true ATE406448T1 (de) 2008-09-15

Family

ID=26800810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99930624T ATE406448T1 (de) 1998-06-24 1999-06-23 Diacylglycerin o-acyltransferase

Country Status (6)

Country Link
EP (1) EP1090026B1 (de)
AT (1) ATE406448T1 (de)
AU (1) AU779423B2 (de)
CA (1) CA2330363C (de)
DE (1) DE69939426D1 (de)
WO (1) WO1999067268A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995301B1 (en) 1999-05-04 2006-02-07 Cargill, Incorporated Plant acyltransferases
CA2372632C (en) * 1999-05-04 2011-02-15 Basil S. Shorrosh Plant acyltransferases
US6552250B1 (en) 2000-06-14 2003-04-22 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Diacylglycerol O-acyltransferase
US6444427B1 (en) * 2000-07-11 2002-09-03 The Regents Of The University Of California Polymorphisms in a diacylglycerol acyltransferase gene, and methods of use thereof
US7045326B2 (en) 2001-02-23 2006-05-16 The Regents Of The University Of California Mono- and diacylglycerol acyltransferases and methods of use thereof
US20020119138A1 (en) 2001-02-26 2002-08-29 Sylvaine Cases Diacylglycerol o-acyltransferase 2alpha (DGAT2alpha)
AU2002325872B2 (en) * 2001-07-06 2008-05-08 Forderverein Biotechnologieforschung E.V. Method for determining the genetic predisposition of a mammal for its milk fat content and/or for its intramuscular fat content
MXPA05001239A (es) 2002-07-31 2005-06-08 Monsanto Technology Llc Secuencias de acidos nucleicos de diacilglicerol aciltransferasa y productos asociados.
US20040185559A1 (en) 2003-03-21 2004-09-23 Isis Pharmaceuticals Inc. Modulation of diacylglycerol acyltransferase 1 expression
AR044152A1 (es) 2003-05-09 2005-08-24 Bayer Corp Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad
CN105123532B (zh) 2006-07-14 2018-12-18 联邦科学技术研究组织 改变水稻的脂肪酸组成
EP2057177B1 (de) 2006-08-04 2012-11-21 Isis Pharmaceuticals, Inc. Zusammensetzungen und ihre verwendung in bezug auf diacylglycerol-acyltransferase 1
NZ554114A (en) * 2007-04-23 2010-01-29 Agres Ltd Plants with an increased ratio of oleosin to TAG synthesising enzymes
CN102202498B (zh) 2008-07-21 2016-09-07 澳大利亚联邦科学与工业研究组织 改良的棉籽油及应用
CA2768737A1 (en) 2008-07-21 2010-01-28 Commonwealth Scientific And Industrial Research Organisation Improved vegetable oils and uses therefor
US9061012B2 (en) 2010-03-30 2015-06-23 Novartis Ag Uses of DGAT1 inhibitors
ES2640100T3 (es) 2010-06-28 2017-10-31 Commonwealth Scientific And Industrial Research Organisation Métodos para producir lípidos
CA3203397A1 (en) 2011-12-27 2013-07-04 Nuseed Global Innovation Ltd Processes for producing lipids
US11639507B2 (en) 2011-12-27 2023-05-02 Commonwealth Scientific And Industrial Research Organisation Processes for producing lipids
US8809026B2 (en) 2011-12-27 2014-08-19 Commonwealth Scientific And Industrial Research Organisation Processes for producing lipids
CA2871503C (en) 2012-04-25 2023-08-29 Commonwealth Scientific And Industrial Research Organisation High oleic acid oils
WO2016004473A1 (en) 2014-07-07 2016-01-14 Commonwealth Scientific And Industrial Research Organisation Processes for producing industrial products from plant lipids
US11020429B2 (en) 2015-11-05 2021-06-01 Juno Therapeutics, Inc. Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy
US11859193B2 (en) 2016-09-02 2024-01-02 Nuseed Global Innovation Ltd. Plants with modified traits
PE20210158A1 (es) 2018-03-16 2021-01-26 Anji Pharmaceuticals Inc Composiciones y metodos para tratar el estrenimiento grave
WO2023085931A1 (en) 2021-11-11 2023-05-19 Koninklijke Nederlandse Akademie Van Wetenschappen Hepatic organoids

Also Published As

Publication number Publication date
WO1999067268A9 (en) 2000-03-23
CA2330363C (en) 2009-10-20
AU4712499A (en) 2000-01-10
EP1090026A4 (de) 2004-05-06
EP1090026B1 (de) 2008-08-27
CA2330363A1 (en) 1999-12-29
AU779423B2 (en) 2005-01-20
WO1999067268A1 (en) 1999-12-29
DE69939426D1 (de) 2008-10-09
EP1090026A1 (de) 2001-04-11

Similar Documents

Publication Publication Date Title
ATE376054T1 (de) Diacylglyzerin o-acyltransferase
DE69939426D1 (de) Diacylglycerin o-acyltransferase
BR9910251A (pt) Estimulação hematopoiética
GR3033630T3 (en) Gene expression elements and the production of chimeric mouse-human antibodies.
HU9403536D0 (en) Dna sequences used in the production of recombinant human bssl/cel in transgenic non-human mammals, and the produced bssl/cel used in infant formulas
DE69835367D1 (de) Gentherapie für gaucher-krankheit
IT8021351A0 (it) Processo per il trattamento di peci nella produzione di manufatti abase di carbonio.
DE69836514D1 (de) Elektrodenkörper, mit diesem versehener Akkumulator, sowie Herstellung des Elektrodenkörpers und des Akkumulators
AU2003266214A1 (en) Human coagulation factor vii polypeptides
ID25950A (id) Katalis-katalis untuk memproduksi aldehid tidak jenuh dan asam karboksilat tidak jenuh dan proses untuk produksi aldehid tidak jenuh dan asam karboksilat tidak jenuh menggunakan katalis
DE69916856D1 (de) Micropartikeln zur verwendung in nadellosen injektion
TW200407425A (en) Human coagulation factor VII polypeptides
DE69334211D1 (de) Multidrug resistenz gen
ATE195552T1 (de) G-csf analoge und verfahren zu ihrer herstellung
DE69901177D1 (de) Platinkomplex, dessen herstellung und dessen therapeutische verwendung
DE3675887D1 (de) Elektronisch leitfaehige stickstoffpolymere, verfahren zur herstellung derselben, elektrochronische anzeigezelle, und diese polymere verwendender elektrochemischer generator.
ID30116A (id) Turunan-turunan piridopiranoazepin, pembuatannya dan penggunaan terapinya
DE69613329D1 (de) Enzym enthaltendes Granulat, Herstellungsmethode und das Granulat enthaltende Zusammensetzungen
DK0885296T3 (da) Et enzym med galactanaseaktivitet
DE3485826D1 (de) Herstellung und verwendung polymerer kugeln.
ATE316140T1 (de) Protein, das die spaltung von beta-carotin katalysiert
BG105779A (bg) Човешки антибиотични протеини
DE3677848D1 (de) Chromosomale dna-sequenz, expressionsvektor fuer menschlichen gewebeplasminogen aktivierenden faktor mit diesem transfektierte, gezuechtete zellen, sowie verfahren zur herstellung des genannten aktivierungsfaktors.
DE3586952D1 (de) Fibrinophiler urokinase-komplex und dessen herstellung.
ITRM930818A0 (it) Procedimento per la produzione in piante di anticorpi ingegnerizzati, anticorpi prodotti e loro uso in diagnosi e terapia.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties